Correlation between Serum Levels of 3,3ʹ,5ʹ-Triiodothyronine and Thyroid Hormones Measured by Liquid Chromatography-Tandem Mass Spectrometry and Immunoassay
Open accessAbstract
OBJECTIVE: For measuring serum 3,3',5'-triiodothyronine (rT3) levels, radioimmunoassay (RIA) has traditionally been used owing to the lack of other reliable methods; however, it has recently become difficult to perform. Meanwhile, liquid chromatography-tandem mass spectrometry (LC-MS/MS) has recently been attracting attention as a novel alternative method in clinical chemistry. To the best of our knowledge, there are no studies to date comparing results of the quantification of human serum rT3 between LC-MS/MS and RIA. We therefore examined the feasibility of LC-MS/MS as a novel alternative method for measuring serum rT3, thyroxine (T4), and 3,5,3'-triiodothyronine (T3) levels. METHODS: Assay validation was performed by LC-MS/MS using quality control samples of rT3, T4, and T3 at 4 various concentrations which were prepared from reference compounds. Serum samples of 50 outpatients in our department were quantified both by LC-MS/MS and conventional immunoassay for rT3, T4, and T3. Correlation coefficients between the 2 measurement methods were statistically analyzed respectively. RESULTS: Matrix effects were not observed with our method. Intra-day and inter-day precisions were less than 10.8% and 9.6% for each analyte at each quality control level, respectively. Intra-day and inter-day accuracies were between 96.2% and 110%, and between 98.3% and 108.6%, respectively. The lower limit of quantification was 0.05 ng/mL. Strong correlations were observed between the 2 measurement methods (correlation coefficient, T4: 0.976, p < 0.001; T3: 0.912, p < 0.001; rT3: 0.928, p < 0.001). CONCLUSIONS: Our LC-MS/MS system requires no manual cleanup operation, and the process after application of a sample is fully automated; furthermore, it was found to be highly sensitive, and superior in both precision and accuracy. The correlation between the 2 methods over a wide range of concentrations was strong. LC-MS/MS is therefore expected to become a useful tool for clinical diagnosis and research.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several laboratories have developed procedures to accurately determine total T4 and total T3 in human plasma or serum and largely agree on concentration ranges, but this consensus has not been achieved for most other TH metabolites.
“While meanwhile several laboratories developed procedures to accurately determine total T4 and total T3 in human plasma or serum and largely agree on concentrations ranges (25, 67–73), this consensus has not been achieved yet for most of the other TH metabolites, which occur at much lower concentrations.”
From 3,5-T2—A Janus-Faced Thyroid Hormone Metabolite Exerts Both Canonical T3-Mimetic Endocrine and Intracrine Hepatic Action (2020) · cites this paper as [70]
The Introduction describes several studies measuring serum T4 and T3 and says rT3 occurs at extremely low levels that make quantification difficult. The Discussion reports strong T4 and T3 correlations for this study and another, but also notes measurement discrepancies. Neither section establishes agreement among laboratories on concentration ranges or a lack of consensus for most other thyroid-hormone metabolites beyond rT3. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Krasowski, M. D., Drees, D., Morris, C. S., Maakestad, J., Blau, J. L., & Ekins, S. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-33 · Cited by 212 · see citing works
Gielen, M., Mesotten, D., Wouters, P. J., Desmet, L., Vlasselaers, D., Vanhorebeek, I., Langouche, L., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2240 · Cited by 22 · see citing works
Flagged first, then by citations
Research works printed but not linked: 26
- [1]Wu AH, French D. Implementation of liquid chromatography/mass spectrometry into the clinical laboratory. Clin Chim Acta. 2013; 420: 4– 10. 10.1016/j.cca.2012.10.026 23085380 · DOI
- [2]Huang SA, Castro Neves LA. Low-T3 Syndrome In: Brent GA editor. Thyroid Function Testing: Endocrine Update, Vol. 28; 2010 pp 13– 14. Available from: http://www.springer.com/series/5917
- [3]Nagao H, Imazu T, Hayashi H, Takahashi K, Minato K. Influence of thyroidectomy on thyroxine metabolism and turnover rate in rats. J Endocrinol. 2011; 210: 117– 123. 10.1530/JOE-10-0484 21478227 · DOI
- [4]Yue B, Rockwood AL, Sandrock T, La'ulu SL, Kushnir MM, Meikle AW. Free thyroid hormones in serum by direct equilibrium dialysis and online solid-phase extraction—liquid chromatography/tandem mass spectrometry. Clin Chem. 2008; 54: 642– 651. 10.1373/clinchem.2007.098293 18258669 · DOI · Paper page
- [5]Kumar AP, Jin H, Jo SC, Kim C, Nam SH, Lee YI. Isomeric discrimination and quantification of thyroid hormones, T3 and rT3, by the single ratio kinetic method using electrospray ionization mass spectrometry. J Am Soc Mass Spectrom. 2010; 21: 14– 22. 10.1016/j.jasms.2009.07.004 19853471 · DOI
- [6]Zhang Y, Conrad AH, Conrad GW. Detection and quantification of 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine by electrospray ionization tandem mass spectrometry. J Am Soc Mass Spectrom. 2005; 16: 1781– 1786. 16182556
- [7]Wang D, Stapleton HM. Analysis of thyroid hormones in serum by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2010; 397: 1831– 1839. 10.1007/s00216-010-3705-9 20437035 PMC3082288 · DOI
- [8]Soukhova N, Soldin OP, Soldin SJ. Isotope dilution tandem mass spectrometric method for T4/T3. Clin Chim Acta. 2004; 343: 185– 190. 15115693 PMC3634919
- [9]Soldin OP, Tractenberg RE, Soldin SJ. Differences between measurements of T4 and T3 in pregnant and nonpregnant women using isotope dilution tandem mass spectrometry and immunoassays: are there clinical implications? Clin Chim Acta. 2004; 347: 61– 69. 15313142 PMC3625640
- [10]Soldin OP, Hilakivi-Clarke L, Weiderpass E, Soldin SJ. Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays. Clin Chim Acta. 2004; 349: 181– 189. 15469872 PMC3625638
- [11]Jonklaas J, Soldin SJ. Tandem mass spectrometry as a novel tool for elucidating pituitary-thyroid relationships. Thyroid. 2008; 18: 1303– 1311. 10.1089/thy.2008.0155 19067639 PMC2857453 · DOI
- [12]Tyan YC, Jong SB, Yang MH, Wu TL, Chung TW, Liao PC, et al Utilizing isotope dilution-matrix-assisted laser desorption ionization-time of flight mass spectrometry as a reference procedure for the radioimmunoassay of serum thyroxine. Clin Chim Acta. 2013; 420: 99– 103. 10.1016/j.cca.2012.10.014 23078848 · DOI
- [13]Chace DH, Singleton S, Diperna J, Aiello M, Foley T. Rapid metabolic and newborn screening of thyroxine (T4) from dried blood spots by MS/MS. Clin Chim Acta. 2009; 403: 178– 183. 10.1016/j.cca.2009.02.012 19254705 · DOI
- [14]Peeters RP, Wouters PJ, van Toor H, Kaptein E, Visser TJ, Van den Berghe G. Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab. 2005; 90: 4559– 4565. 15886232
- [15]Mebis L, Langouche L, Visser TJ, Van den Berghe G. The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness. J Clin Endocrinol Metab. 2007; 92: 3330– 3333. 17504898
- [17]Visser WE, Vrijmoeth P, Visser FE, Arts WF, van Toor H, Visser TJ. Identification, functional analysis, prevalence and treatment of monocarboxylate transporter 8 (MCT8) mutations in a cohort of adult patients with mental retardation. Clin Endocrinol(Oxf). 2013; 78: 310– 315. 22924588
- [18]Premachandra BN. Radioimmunoassay of reverse triiodothyronine. J Clin Endocrinol Metab. 1978; 47: 746– 750. 263323
- [20]Ismail AA. Interference from endogenous antibodies in automated immunoassays: what laboratorians need to know. J Clin Pathol. 2009; 62: 673– 678. 10.1136/jcp.2008.055848 19638536 · DOI
- [21]Sakai H, Fukuda G, Suzuki N, Watanabe C, Odawara M. Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH. Endocr J. 2009; 56: 435– 440. 19336948
- [22]Halsall DJ. Antibody interference in immunoassay: know your enemy. Ann Clin Biochem. 2013; 50: 397– 399. 10.1177/0004563213499554 23888058 · DOI
- [23]Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab. 2013; 27: 647– 661. 10.1016/j.beem.2013.05.011 24094636 · DOI
- [24]Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem. 1999; 45: 942– 956. 10388468
- [25]Tai SS, Sniegoski LT, Welch MJ. Candidate reference method for total thyroxine in human serum: use of isotope-dilution liquid chromatography-mass spectrometry with electrospray ionization. Clin Chem. 2002; 48: 637– 642. 11901062
- [26]Tai SS, Bunk DM, White E, Welch MJ. Development and evaluation of a reference measurement procedure for the determination of total 3,3',5-triiodothyronine in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem. 2004; 76: 5092– 5096. 15373447
- [27]Jonklaas J, Sathasivam A, Wang H, Gu J, Burman KD, Soldin SJ. Total and free thyroxine and triiodthyronine: measurement discrepancies, particularly in inpatients. Clin Biochem. 2014; 47: 1272– 1278 10.1016/j.clinbiochem.2014.06.007 24936679 PMC4187214 · DOI · Paper page
- [28]Chopra IJ. A radioimmunoassay for measurement of 3,3′,5′-triiodothyronine (reverse T3). J Clin Invest. 1974; 54: 583– 592 4211761 PMC301591
Cited by
Sorted by citations
Clinical and laboratory aspects of 3,3′,5′-triiodothyronine (reverse T3)
Halsall, D. J., & Oddy, S. (2021) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563220969150 · Cited by 28 · see citing works
Köhrle, J., Lehmphul, I., Pietzner, M., Renko, K., Rijntjes, E., Richards, K., Anselmo, J., Danielsen, M., & Jonklaas, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00787 · Cited by 23 · see citing works
Binding Characteristics of Thyroid Hormone Distributor Proteins to Thyroid Hormone Metabolites
Jongejan, R. M. S., Meima, M. E., Visser, W. E., Korevaar, T. I. M., van den Berg, S. A. A., Peeters, R. P., & de Rijke, Y. B. (2022) · Thyroid® · doi:10.1089/thy.2021.0588 · Cited by 20 · see citing works
Köhrle, J., & Richards, K. H. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1175-4610 · Cited by 7 · see citing works
- Authors
- Sakai, H., Nagao, H., Sakurai, M., Okumura, T., Nagai, Y., Shikuma, J., Ito, R., Imazu, T., Miwa, T., & Odawara, M.
- Affiliations
- Tokyo Medical University (JP)
- ASKA Pharmaceutical (Japan) (JP)
- Corresponding author
- Sakai, Hiroyuki
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-01
- Volume
- 10
- Issue
- 10
- Pages
- e0138864
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4591014
- OpenAlex
- W2266922729
- Cited by
- 19
- References
- 2
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 2
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-07-07)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
- Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
- Keywords
- reverse T3, thyroxine, triiodothyronine, thyroid hormones, serum hormone measurement, LC-MS/MS, radioimmunoassay, method comparison, assay validation, automated sample analysis, matrix effects, precision and accuracy, lower limit of quantification, thyroid function tests
- MeSH terms
- Blood Chemical Analysis, Chromatography, Liquid, Feasibility Studies, Female, Humans, Male, Middle Aged, Radioimmunoassay, Thyroxine, Triiodothyronine, Triiodothyronine, Reverse, Reproducibility of Results, Linear Models, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review